Denali Therapeutics shares owned by Assetmark
Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Assetmark
from 13F filings
Historical chart of Assetmark investment in Denali Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Denali Therapeutics held by Assetmark consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Denali Therapeutics by Assetmark
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $76k | 3.6k | 21.46 |
| 2023-09-30 | $44k | 2.1k | 20.63 |
| 2023-06-30 | $43k | 1.4k | 29.51 |
| 2023-03-31 | $18k | 772 | 23.04 |
| 2022-12-31 | $16k | 574 | 27.81 |
| 2022-09-30 | $13k | 438 | 29.68 |